Last updated on July 2019

A Phase III Study of Efficacy and Safety of Ligelizumab in the Treatment of CSU in Adolescents and Adults Inadequately Controlled With H1-antihistamines


Brief description of study

The purpose of this study is to establish efficacy and safety of ligelizumab in adolescent and adult subjects with CSU who remain symptomatic despite standard of care treatment by demonstrating better efficacy over omalizumab.

The study population will consist of approximately 1050 male and female subjects aged 12 years who have been diagnosed with CSU and who remain symptomatic despite the use of H1-antihistamines. Of these, approximately 1000 adults and 50 adolescents are planned for inclusion in the study.

This is a multi-center, randomized, double-blind, active- and placebo-controlled, parallel-group study. There is a screening period of up to 28 days, a 52 week double-blind treatment period, and a 12 week post-treatment follow-up period.

Clinical Study Identifier: NCT03580369

Find a site near you

Start Over

Novartis Investigative Site

Gilbert, AZ United States
  Connect »

Novartis Investigative Site

Litchfield Park, AZ United States
  Connect »

Novartis Investigative Site

Little Rock, AR United States
  Connect »

Novartis Investigative Site

Huntington Beach, CA United States
  Connect »

Novartis Investigative Site

Long Beach, CA United States
  Connect »

Novartis Investigative Site

Los Angeles, CA United States
  Connect »

Novartis Investigative Site

Colorado Springs, CO United States
  Connect »

Novartis Investigative Site

Tallahassee, FL United States
  Connect »

Novartis Investigative Site

Marietta, GA United States
  Connect »

Novartis Investigative Site

Savannah, GA United States
  Connect »

Novartis Investigative Site

Evansville, IN United States
  Connect »

Novartis Investigative Site

Indianapolis, IN United States
  Connect »

Novartis Investigative Site

Florence, KY United States
  Connect »

Novartis Investigative Site

Waldorf, MD United States
  Connect »

Novartis Investigative Site

Clarkston, MI United States
  Connect »

Novartis Investigative Site

Ypsilanti, MI United States
  Connect »

Novartis Investigative Site

Minneapolis, MN United States
  Connect »

Novartis Investigative Site

Asheville, NC United States
  Connect »

Novartis Investigative Site

Gastonia, NC United States
  Connect »

Novartis Investigative Site

Cincinnati, OH United States
  Connect »

Novartis Investigative Site

Plymouth Meeting, PA United States
  Connect »

Novartis Investigative Site

Goodlettsville, TN United States
  Connect »

Novartis Investigative Site

Pflugerville, TX United States
  Connect »

Novartis Investigative Site

San Antonio, TX United States
  Connect »

Novartis Investigative Site

South Burlington, VT United States
  Connect »

Novartis Investigative Site

Ciudad Autonoma de Bs As, Argentina
  Connect »

Novartis Investigative Site

Capital Federal, Argentina
  Connect »

Novartis Investigative Site

Montpellier cedex 5, France
  Connect »

Novartis Investigative Site

Pierre Benite Cedex, France
  Connect »

Novartis Investigative Site

Guatemala City, Guatemala
  Connect »

Novartis Investigative Site

Daegu, Korea, Republic of
  Connect »

Novartis Investigative Site

Wonju, Korea, Republic of
  Connect »

Novartis Investigative Site

Bundang Gu, Korea, Republic of
  Connect »

Novartis Investigative Site

Hwaseong si, Korea, Republic of
  Connect »

Novartis Investigative Site

Suwon si, Korea, Republic of
  Connect »

Novartis Investigative Site

Seoul, Korea, Republic of
  Connect »

Novartis Investigative Site

Gwangju, Korea, Republic of
  Connect »

Novartis Investigative Site

Incheon, Korea, Republic of
  Connect »

Novartis Investigative Site

Moscow, Russian Federation
  Connect »

Novartis Investigative Site

Rostov on Don, Russian Federation
  Connect »

Novartis Investigative Site

Ryazan, Russian Federation
  Connect »

Novartis Investigative Site

Saratov, Russian Federation
  Connect »

Novartis Investigative Site

Smolensk, Russian Federation
  Connect »

Novartis Investigative Site

St Petersburg, Russian Federation
  Connect »

Novartis Investigative Site

St. Petersburg, Russian Federation
  Connect »

Novartis Investigative Site

Hospitalet de Llobregat, Spain
  Connect »

Novartis Investigative Site

Okmeydani / Istanbul, Turkey
  Connect »